Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial

Published:2017-07 Issue:7 Volume:17 Page:745-753
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Rivera Luis,Pedersen Rasmus S,Peña Lourdes,Olsen Klaus J,Andreasen Lars V,Kromann Ingrid,Nielsen Pernille I,Sørensen Charlotte,Dietrich Jes,Bandyopadhyay Ananda S,Thierry-Carstensen Birgit

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference26 articles.

1. Polio eradication & endgame strategic plan 2013–2018,2013

2. Polio vaccination: past, present and future;Bandyopadhyay;Future Microbiol,2015

3. Affordable inactivated poliovirus vaccine: strategies and progress;Okayasu;J Infect Dis,2014

4. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial;Sutter;Lancet,2010

5. Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial;Sutter;Lancet,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enteroviruses: Polio;Viral Infections of Humans;2023

2. Poliovirus Vaccine—Inactivated;Plotkin's Vaccines;2023

3. Persistence of protective anti-poliovirus antibody levels in 4-year-old children previously primed with Picovax®, a trivalent, aluminium-adjuvanted reduced dose inactivated polio vaccine;Vaccine;2022-09

4. Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats;Biologicals;2022-01

5. Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population;Vaccine;2021-03